News Releases

IBBR Receives Grant to Explore Next Generation Multi-Specific Antibody Therapeutic: Next Step towards a Cure for HIV?


The goal is to develop and test a “first-in-class multi-specific antibody“, which could offer dramatic advantages over current treatments for AIDS patients, help eliminate hidden reservoirs of HIV, and potentially deliver on the promise of a long-awaited HIV cure.

(Rockville, MD, September 5, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $115,000 grant to further develop and commercialize a multi-specific antibody as a therapeutic for HIV.  The grant is funded under the Maryland Innovation Initiative (MII) by the Maryland... Read More

Montgomery County High School Interns Showcase Their Achievements


August 21, 2017 -- The University of Maryland Institute for Bioscience and Biotechnology Research (IBBR) solicits applications each year for summer and year-long internships open to Montgomery County high school juniors (age 16 and over). On Wednesday, August 16, this year’s summer interns presented their findings via posters they created, as IBBR faculty, post-doctoral fellows, graduate students and staff talked with them about what they had learned. 

Exploring Biomedical Applications of Multifunctional Polyphosphazenes


Renowned IBBR chemist to speak at the American Chemical Society National Meeting

(Rockville, MD, August 16, 2017) Alexander K. Andrianov, Ph.D., Research Professor at the University of Maryland’s Institute for Bioscience and Biotechnology Research (IBBR), whose research led to the formation of Innovo Biopolymers LLC, is a co-organizer of a “Polyphosphazenes in Biomedicine, Engineering & Pioneering Synthesis” Symposium at the 254th American Chemical Society (ACS) Meeting, scheduled for August 20-24, 2017, in Washington, DC.  

Decade of TMV research leads to never-before-seen microsystems for energy storage, biosensors and self-sustaining systems


June 21, 2017 -- Since 2007, University of Maryland professors Reza Ghodssi (Electrical and Computer Engineering and Institute for Systems Research) and James Culver (Plant Sciences and Landscape Architecture and Institute of Bioscience and Biotechnology Research) have partnered with colleagues from materials science, chemistry and bioengineering to create devices using the Tobacco mosaic virus as a biological nanoscaffold. The work has resulted in never-before-possible microsystems for energy storage and biological sensors.

IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine


(Rockville, MD, June 12, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $6.0 million grant entitled, “Structure-Based Vaccine Design for Hepatitis C Virus”, to develop a novel prophylactic vaccine to prevent hepatitis C virus (HCV) infection. The grant is funded by the National Institutes of Health (NIH) and the research will take place over a five-year period.  

IBBR faculty win two Maryland Innovation Initiative (MII) grants


(Rockville, MD, June 5, 2017) The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded two $115,000 grants to commercialize technologies based on improving protein-based therapeutics utilizing a novel biopolymer and an alternate way to treat Niemann-Pick disease patients. The grants are funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research and the state’s efforts to foster economic development in Maryland. 

Genisphere Begins Collaborative and Sponsored Research Program with the University of Maryland


HATFIELD, Pa - April 26, 2017 - Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University of Maryland, through Dr. Silvia Muro. The overall goal of the partnership is to study the pharmacokinetics and pharmacodynamics of various 3DNA designs and formulations after in vivo administration. Additional aims involve targeting diseases of the vasculature as well as inflammatory responses, demonstrating various methods of endocytosis via appropriate targeting moieties, and studying the... Read More

IBBR Receives Award to Develop Drought-Tolerant Plants


(Rockville, Maryland) The Institute for Bioscience and Biotechnology Research has been awarded a $100,000 grant to test the broader applicability of a technology platform invented by one of its leading scientists towards engineering drought-tolerant, agriculturally important crops.  The grant is funded by the Maryland Innovation Initiative (MII) as part of the Technology Council of Maryland’s (TEDCO) effort to support commercialization of academic-based scientific research as part of the state’s efforts to foster economic development in Maryland.

IBBR Fellow, Shunyuan Xiao, Ph.D.,... Read More

Bentley Leads Team of Researchers Working to Develop Electrogenetic Device for Activating Gene Expression via Electrodes


FOR IMMEDIATE RELEASE   
                                               

Media Contact: Alyssa Wolice, 301-405-3936
 

UMD Researchers Develop Electrogenetic Device for Activating Gene Expression via Electrodes

System Holds Promise for Study of Biological Systems, Biosensors and Bio-hybrid Devices

 

College Park, Md. – Researchers from the University of Maryland (UMD) are working to develop an electrogenetic device to direct gene expression, an achievement that holds promise for... Read More

University of Maryland Key Partner in New National Institute for Innovation of Manufacturing Biopharmaceuticals


Contacts: 

Pamela R. M. Phetphongsy 301-405-6266, Lee Tune 301-405-4679

COLLEGE PARK, Md. – The University of Maryland will be a key partner in a new institute to advance U.S. leadership in pharmaceutical manufacturing that was announced by U.S. Secretary of Commerce Penny Pritzker on Friday, December 16, 2016... Read More